- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03665558
Effect of Pacing on Aortic dP/dt Values
Effect of DDD Pacing Titrated by Stepwise Changing of AVD on Aortic dP/dt
The maximum value of rate of left ventricular pressure increase, denoted by left ventricular peak dP/dt value (dP/dt max), corresponds to the highest point on the curve of first derivative of ventricular pressure curve with respect to time. It is one of the important systolic performance parameters, which is primarily determined by ventricular contractility, and emerges in isovolumetric contraction phase when aortic valves are closed. Thus it is not influenced by parameters beyond ventricle such as aortic valve area, aortic elastance and peripheral resistance. Despite these unique advantageous, the main reason for its limited usage in assessing ventricular systolic performance instead of commonly used ejection fraction is the difficulties in its calculation, which requires incessant intraventricular pressure recordings.
The maximum value of acceleration rate of aortic pressure increase can be named as aortic peak dP/dt. It, likewise, corresponds to the maximum value of first derivative of pressure curve with respect to time.
Since it is one of the principal determining factors of aortic peak dP/dt, changing left ventricular contractility thereby left ventricular peak dP/dt value is expected to change aortic peak dP/dt in the same direction since all other variables being unchanged. Yet to conclude the extent of this association and magnitude of change, measuring these parameters for various contractility levels is necessary. In addition, impact of decreasing left ventricular peak dP/dt by gradually lowering ventricular contractility upon aortic peak dP/dt has not been investigated in previous studies.
In the present study, changes in left ventricular and aortic peak dP/dt values in response to gradual reduction in LV contractility with stepwise changing (decremental shortening) atrio-ventricular delay (AVD) by dual chamber pacing will be investigated in patients without systolic dysfunction.
Study Overview
Detailed Description
The maximum value of rate of left ventricular pressure increase, denoted by left ventricular peak dP/dt value (dP/dt max), corresponds to the highest point on the curve of first derivative of ventricular pressure curve with respect to time. It is one of the important systolic performance parameters, which is primarily determined by ventricular contractility, and emerges in isovolumetric contraction phase when aortic valves are closed. Thus it is not influenced by parameters beyond ventricle such as aortic valve area, aortic elastance and peripheral resistance. Despite these unique advantageous, the main reason for its limited usage in assessing ventricular systolic performance instead of commonly used ejection fraction is the difficulties in its calculation, which requires incessant intraventricular pressure recordings.
The maximum value of acceleration rate of aortic pressure increase can be named as aortic peak dP/dt. It, likewise, corresponds to the maximum value of first derivative of pressure curve with respect to time. Unlike left ventricular peak dP/dt, it emerges after aortic valve opens in early systolic ejection phase and thus is influenced by parameters beyond ventricle in addition to left ventricular contractility such as aortic elastance and compliance, vascular resistance, interference of forward and backward propagating pressure waves, stroke volume and its ejection rate (dV/dt). Notably, aortic peak dP/dt can be expected to be one of principal determinants in pressure-related damages in the vascular system. In structures exposed to variable pressures, the extent of damage depends on the magnitude and rate of acceleration of applied pressure in addition to susceptibility of the structures. Whether this mechanism, which has numerous implications from the real world, operates in the organism as well can be exemplified by the pulse pressure, which is an independent risk factor for adverse cardiovascular events apart from systolic and diastolic blood pressure levels. A wide pulse pressure suggests an accelerated rate of pressure increase. Therefore applications lowering left ventricular and aortic peak dP/dt values may open a new therapeutic avenue in management of pressure-related vascular damages such as aortic aneurisms. However, aortic peak dP/dt concept is seldom found a place even in research articles.
Since it is one of the principal determining factors of aortic peak dP/dt, changing left ventricular contractility thereby left ventricular peak dP/dt value is expected to change aortic peak dP/dt in the same direction since all other variables being unchanged. Yet to conclude the extent of this association and magnitude of change, measuring these parameters for various contractility levels is necessary. In this context, it has been demonstrated that narrowing of the QRS complex by cardiac resynchronization therapy (CRT) was shown to increase left ventricular peak dP/dt value. This finding strongly suggests that widening of the QRS complex, on the contrary, will decrease left ventricular peak dP/dt value. However, impact of decreasing left ventricular peak dP/dt by gradually lowering ventricular contractility upon aortic peak dP/dt has not been investigated in previous studies.
In the present study, changes in left ventricular and aortic peak dP/dt values in response to gradual reduction in left ventricular (LV) contractility with stepwise changing (decremental shortening) atrio-ventricular delay (AVD) by dual chamber pacing will be investigated in patients without LV systolic dysfunction.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34290
- Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Normal left ventricular systolic function
Exclusion Criteria:
- Abnormal left ventricular systolic function with ejection fraction < 50%
- Presence of severe coronary artery disease
- Presence of valvular heart disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Aortic dP/dt in sinus rhythm
Left ventricular and aortic dP/dt values were recorded at baseline condition while patients are on sinus rhythm.
|
|
|
Active Comparator: Aortic dP/dt during DDD pacing
Patients will be their own control.
Aortic and ventricular pressures will be recorded under temporary DDD pacing again and these data collected at every pacing steps will be compared to the pressures recorded at baseline condition.
|
Measurements will be performed in patients otherwise undergoing invasive catheterization procedure.
Baseline ventricular and aortic hemodynamic parameters (continuous pressure recordings) will be recorded.
Thereafter, DDD pacing with stepwise changing of the AV delay will be performed.
During each pacing steps left ventricular and aortic pressures at different aortic levels will be continuously recorded.
From these hemodynamic data, left ventricular and aortic dP/dt values will be calculated off line.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changing in aortic dP/dt in response to DDD pacing
Time Frame: At the end of the stepwise pacing procedure completed
|
Changing in aortic dP/dt in response to DDD pacing will be determined
|
At the end of the stepwise pacing procedure completed
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 843-1075
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Diseases
-
W.L.Gore & AssociatesRecruitingAortic Arch Aneurysm | Aortic Arch DissectionUnited States
-
Aiatella OyRecruitingAortic Aneurysm | Aortic Aneurysm, Thoracoabdominal | Aortic Aneurysm Abdominal | Aortic Aneurysm and DissectionUnited States, Brazil
-
W.L.Gore & AssociatesCMIC Co, Ltd. JapanRecruitingThoracoabdominal Aortic Aneurysm | Pararenal Aortic AneurysmJapan
-
Cook Research IncorporatedRecruitingThoracoabdominal Aortic Aneurysm | Aortic Arch Aneurysm | Complex Abdominal Aortic Aneurysm | Chronic Aortic DissectionDenmark, France, United Kingdom, Germany, Italy, Sweden
-
University of South FloridaMedtronic; Sanford HealthActive, not recruiting
-
W.L.Gore & AssociatesRecruitingAneurysm | Thoracic Aortic Aneurysm | Dissection, Aortic | TAA Thoracoabdominal Aortic Aneurysm | Transection AortaNetherlands, Italy, Denmark, Germany, Sweden, United Kingdom, Austria, Spain, Greece
-
University of BolognaCompletedThoracoabdominal Aortic Aneurysm | Ruptured Thoracic Aneurysm | Ruptured Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm, RupturedItaly
-
University of Alabama at BirminghamCook Group IncorporatedRecruitingAortic Dissection | Juxtarenal Aortic Aneurysm | Suprarenal Aortic Aneurysm | Thoracoabdominal Aortic Aneurysm | Penetrating Aortic Ulcer | Aortic Arch AneurysmUnited States
-
Baptist Health South FloridaBolton Medical; William Cook AustraliaRecruitingThoracoabdominal Aortic Aneurysm | Aortic Arch AneurysmUnited States
-
Peking Union Medical College HospitalChanghai Hospital; Fudan University; First Affiliated Hospital, Sun Yat-Sen University and other collaboratorsRecruitingThoracoabdominal Aortic Aneurysm | Complex Aortic Aneurysms | Endovascular RepairChina
Clinical Trials on Temporary DDD pacing
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Province Hospital of Traditional Chinese Medicine; Xuzhou Medical University and other collaboratorsUnknown
-
Ascension HealthMedtronicRecruitingSymptomatic First-degree Heart BlockUnited States
-
Medtronic Hellas Medical Devices ΑEEWithdrawn
-
Swift Sync, Inc.Regulatory and Quality SolutionsCompletedHeart Block | Valve Heart DiseaseParaguay
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonNot yet recruitingRight Ventricular Dysfunction | Pacemaker-Induced Cardiomyopathy | Tricuspid Regurgitation
-
Region SkaneTerminatedHeart Failure, Systolic | Left Bundle Branch Block | Wide QRS ComplexSweden
-
Chinese University of Hong KongNot yet recruitingPacemaker Implantation | Temporary Cardio-neural PacingHong Kong
-
University of California, San FranciscoRecruitingRight Ventricular Dysfunction | Pulmonary Artery HypertensionUnited States
-
Guidant CorporationCompletedAcute Myocardial InfarctionNetherlands
-
Chinese University of Hong KongNot yet recruitingCardio-neural PacingHong Kong